Nancy Wysenski

Nancy Wysenski

Directeur/Membre du Conseil chez CYTOKINETICS, INCORPORATED

Fortune : 3 M $ au 31/05/2026

68 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Nancy J.
Wysenski
was the founder of EMD Pharmaceuticals, Inc., founded in 1999, where the title held was President & Chief Executive Officer from 2001 to 2006.
Current jobs include Director at Alkermes, Inc. since 2013, Independent Director at Cytokinetics, Inc. since 2020, and President-Research Triangle Park Chapter at Healthcare Businesswomens Association.
Former jobs include Director at North American Scientific, Inc. and Reata Pharmaceuticals, Inc.; Independent Director at Tetraphase Pharmaceuticals, Inc. from 2014 to 2020; Independent Director at Inovio Pharmaceuticals, Inc. from 2015 to 2017; Lead Independent Director at Alkermes Plc from 2022 to 2023; Independent Director at Dova Pharmaceuticals, Inc. from 2018 to 2019; Independent Director at Provention Bio, Inc. from 2020 to 2023; Chief Operating Officer at Indevus Pharmaceuticals, Inc. in 2009; Chief Commercial Officer & Executive VP at Vertex Pharmaceuticals, Inc. from 2011 to 2012; Chief Operating Officer at Endo Health Solutions, Inc. from 2007 to 2009; Senior Vice President-Operations at NetGenics, Inc.; Chief Operating Officer at Endo Pharmaceuticals, Inc. from 2007 to 2009; Vice President-Field Sales at Astra Merck, Inc. from 1984 to 1998; and Trustee at North Carolina Central University.
Education includes an MBA from Baldwin-Wallace College and undergraduate studies at Kent State University (Ohio).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/05/2026 33 917 ( 0,03 % ) 3 M $ 31/05/2026

Postes actifs de Nancy Wysenski

SociétésPosteDébut
CYTOKINETICS, INCORPORATED Directeur/Membre du Conseil 20/11/2020
Directeur/Membre du Conseil 01/05/2013
Corporate Officer/Principal -

Anciens postes connus de Nancy Wysenski

SociétésPosteFin
ALKERMES PLC Directeur/Membre du Conseil 08/12/2023
PROVENTION BIO, INC. Directeur/Membre du Conseil 27/04/2023
TETRAPHASE PHARMACEUTICALS, INC. Directeur/Membre du Conseil 28/07/2020
DOVA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 12/11/2019
INOVIO PHARMACEUTICALS, INC. Directeur/Membre du Conseil 12/05/2017
Voir l'expérience en détail de Nancy Wysenski

Formation de Nancy Wysenski

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Nancy Wysenski
🔇